Higher plasma levels of IL-21, as well as an increase in the frequency of IL-21-expressing CD4+ T cells, are found in SLE patients as compared to controls, correlating with the number of switched memory B cells and with several markers of disease severity (89, 91, 95, 100–104). Here, IL21 is linked to systemic lupus erythematosus.